Bioequivalence testing of combination products to be made compulsory from 2012

Published: 2009-08-03 06:59:00

Updated: 2009-08-03 06:59:00

The bioequivalence testing of combined generic medications is expected to be mandatory from 2012 by phases in a bid to ensure their safety and efficacy over original medications, according to the Korea Food and Drug Administration.

Under the plan, the testing will be applicable to frequently p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK